心脏缩中的长非编码RNAs
Nicolò Mangraviti1, Leon J De Windt1
1Department of Molecular Genetics, Faculty of Science and Engineering, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands.
Frontiers in molecular medicine
|August 1, 2024
概括
长非编码RNAs (lncRNAs) 显示了对心脏病的治疗潜力. 对心脏lncRNA机制的进一步研究可能会导致对心脏缩等疾病的新治疗方法.
科学领域:
- 心血管生物学 心血管生物学
- 分子遗传学 分子遗传学
- 在RNA生物学,RNA生物学.
背景情况:
- 心脏病仍然是一个重要的医疗挑战,治疗策略有限.
- 全基因组测序揭示了非编码RNA (ncRNA) 作为基因表达的关键调节者.
- 长非编码RNAs (lncRNAs) 和循环RNAs (circRNAs) 由于它们的调节功能,为新的治疗干预提供了潜力.
研究的目的:
- 探索心脏长非编码RNAs (lncRNAs) 的生物学.
- 审查支持lncRNAs在治疗心脏缩中的治疗益处的证据.
- 确定利用 lncRNAs 来治疗心血管疾病的挑战和未来方向.
主要方法:
- 对心脏生物学中lncRNA功能的现有文献的综述.
- 分析了研究 lncRNAs 在心脏缩中的作用.
- 探索目前用于lncRNA识别和调制的方法.
主要成果:
- lncRNAs在心脏缩和其他心血管疾病的发展中起着至关重要的作用.
- 实验研究证实了lncRNAs作为治疗点的价值.
- 尽管在识别和表达分析方面存在挑战,但在lncRNA注释方面仍在取得进展.
结论:
- 心脏 lncRNAs 代表了开发心脏病治疗新疗法的一个有希望的领域.
- 了解 lncRNA 作用机制对于其临床应用至关重要.
- 需要进一步的研究来完善调节lncRNA表达的方法,并充分利用它们的治疗潜力.
相关概念视频
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Types of RNA
5.7K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.7K
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Formation of Muscle Fibers from Myoblasts
4.8K
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
4.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
413
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
413
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K


